Gene Expression Patterns in Ovarian Carcinomas
-
Published:2003-11
Issue:11
Volume:14
Page:4376-4386
-
ISSN:1059-1524
-
Container-title:Molecular Biology of the Cell
-
language:en
-
Short-container-title:MBoC
Author:
Schaner Marci E.1, Ross Douglas T.1, Ciaravino Giuseppe1, Sørlie Therese12, Troyanskaya Olga1, Diehn Maximilian1, Wang Yan C.1, Duran George E.1, Sikic Thomas L.1, Caldeira Sandra1, Skomedal Hanne2, Tu I-Ping1, Hernandez-Boussard Tina1, Johnson Steven W.3, O'Dwyer Peter J.3, Fero Michael J.1, Kristensen Gunnar B.2, Børresen-Dale Anne-Lise2, Hastie Trevor1, Tibshirani Robert1, van de Rijn Matt1, Teng Nelson N.1, Longacre Teri A.1, Botstein David1, Brown Patrick O.1, Sikic Branimir I.1
Affiliation:
1. Stanford University School of Medicine, Stanford, California, 94305-5151 2. Norwegian Radium Hospital, 0310 Oslo, Norway 3. University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6055
Abstract
We used DNA microarrays to characterize the global gene expression patterns in surface epithelial cancers of the ovary. We identified groups of genes that distinguished the clear cell subtype from other ovarian carcinomas, grade I and II from grade III serous papillary carcinomas, and ovarian from breast carcinomas. Six clear cell carcinomas were distinguished from 36 other ovarian carcinomas (predominantly serous papillary) based on their gene expression patterns. The differences may yield insights into the worse prognosis and therapeutic resistance associated with clear cell carcinomas. A comparison of the gene expression patterns in the ovarian cancers to published data of gene expression in breast cancers revealed a large number of differentially expressed genes. We identified a group of 62 genes that correctly classified all 125 breast and ovarian cancer specimens. Among the best discriminators more highly expressed in the ovarian carcinomas were PAX8 (paired box gene 8), mesothelin, and ephrin-B1 (EFNB1). Although estrogen receptor was expressed in both the ovarian and breast cancers, genes that are coregulated with the estrogen receptor in breast cancers, including GATA-3, LIV-1, and X-box binding protein 1, did not show a similar pattern of coexpression in the ovarian cancers.
Publisher
American Society for Cell Biology (ASCB)
Subject
Cell Biology,Molecular Biology
Reference65 articles.
1. Alizadeh, A., Eisen, M., Botstein, D., Brown, P.O., and Staudt, L.M. (1998). Probing lymphocyte biology by genomic-scale gene expression analysis. J. Clin. Immunol. 18, 373-379. 2. Alizadeh, A.A. et al. (2000). Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511. 3. Altaras, M.M., Aviram, R., Cohen, I., Cordoba, M., Weiss, E., and Beyth, Y. (1991). Primary peritoneal papillary serous adenocarcinoma: clinical and management aspects. Gynecol. Oncol. 40, 230-236. 4. Alter, O., Brown, P.O., and Botstein, D. (2000). Singular value decomposition for genome-wide expression data processing and modeling. Proc. Natl. Acad. Sci. USA 97, 10101-10106. 5. Arner, E.S., Nakamura, H., Sasada, T., Yodoi, J., Holmgren, A., and Spyrou, G. (2001). Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase, and glutaredoxin by cis-diamminedichloroplatinum (II) and its major metabolite, the glutathione-platinum complex. Free Radic. Biol. Med. 31, 1170-1178.
Cited by
282 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|